Persist AI, an AI and robotics-powered pharmaceutical formulation research company, today announced a strategic collaboration with Microsize and Micromacinazione, pioneers in pharmaceutical ...
Nottingham-based Quotient Sciences has launched what it believes is the world’s first clinical trial of a drug formulation ...
Quotient Sciences today announces the successful initiation of a clinical study evaluating a novel drug product developed ...
High-concentration formulations and patient centricity are challenges to the formulation of biosimilars, which already face patent protection barriers. Biosimilar formulation development requires ...
Optimizing formulation and API synthesis is critical for product success. Technology providers advance chemocatalysis for olefin metathesis and asymmetric reactions in API synthesis. And ...
Solubility is fundamental in successfully developing all classes of therapeutic biopolymers. Contact with stressors related to mechanical stirring or changes in buffer conditions may cause ...
As a contract research and development biotechnology firm, CD Formulation establishes new benchmarks for health care product development by delivering extensive product formulation services. From ...
The global formulation development outsourcing industry was estimated at $22.5 billion in 2021, and is anticipated to hit $51.9 billion by 2031, registering a CAGR of 9% from 2022 to 2031. The ...
Clinical evaluation of several modified release once-daily formulations of danuglipron resulted in encouraging pharmacokinetic data for several candidates with one showing the most favorable profile ...
CD Formulation has recently introduced liposome formulations, which are remarkably better at absorption, stability, and release. NY, UNITED STATES, December 13, 2024 /EINPresswire / -- CD Formulation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results